Synthesis and biological interest of structured docosahexaenoic acid-containing triacylglycerols and phospholipids

Current Organic Chemistry

Volumn 17, Issue 8, 2013, Pages 841-847

  Picq, Madeleine ^a   Bernoud Hubac, Nathalie ^a   Lagarde, Michel ^a  

^a Univ Lyon   (France)

Author keywords

Chemistry; DHA; Fat; Lipase; Lipids; Nutrition

Indexed keywords

GLYCEROL; NUTRITION;

DOCOSAHEXAENOIC ACID; HEALTH BENEFITS; LIPID MOLECULES; N-3 FATTY ACIDS; NATURALLY OCCURRING; PROPERTY; STATES OF KNOWLEDGE; STRUCTURED LIPIDS; TRIACYLGLYCEROLS; WELL-DEFINED STRUCTURES;

PHOSPHOLIPIDS;

EID: 84878667652     PISSN: 13852728     EISSN: None     Source Type: Journal    
DOI: 10.2174/1385272811317080009     Document Type: Review

References (73)

1. Nakamura, T.; Tokunaga, K.; Shimomura, L.; Nishida, M.; Yoshida, S.; Kotani, K.; Islam, A.H.; Keno, Y.; Kobatake, T.; Nagai, Y.; Fujioka, S.; Tarui, S.; Matsuzawa, Y. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis, 1994, 107, 239-246.
2. Formiguera, X.; Canton, A. Obesity: Epidemiology and clinical aspects. Best. Pract. Res. Clin. Gastroenterol., 2004, 18, 1125-1146.
3. Solfrizzi, V.; Panza, F.; Frisardi, V.; Seripa, D.; Logroscino, G.; Imbimbo, B.P.; Pilotto, A. Diet and Alzheimer's disease risk factors or prevention: the current evidence. Expert. Rev. Neurother., 2011, 11, 677-708.
4. Vessby, B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr. Opin. Lipidol., 2003, 14, 15-19.
5. Chen, S.; Chen, R. Docosahexaenoic acid-containing phospholipids and triglycerides based nutritional supplements. Recent Pat. Food. Nutr. Agric., 2010, 2, 213-220.
6. Giudetti, A.M.; Cagnazzo, R. Beneficial effects of n-3 PUFA on chronic airway inflammatory diseases. Prostaglandins Other. Lipid. Mediat., 2012, 99, 57-67.
7. Jump, D.B. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr. Opin. Lipidol., 2008, 19, 242-247.
8. Souza, L.L.; Cordeiro, A.; Oliveira, L.S.; de Paula, G.S.; Faustino, L.C.; Ortiga-Carvalho, T.M.; Oliveira, K.J.; Pazos-Moura, C.C. Thyroid hormone contributes to hypolipidemic effect of polyunsaturated fatty acids from fish oil: in vivo evidence for cross talking mechanisms. J. Endocrinol., 2011, 211, 65-72.
9. De Caterina, R.; Madonna, R.; Bertolotto, A.; Schmidt, E.B. N-3 fatty acids in the treatment of diabetic patients. Diabetes Car., 2007, 30, 1012-1026.
10. Coste, T.; Gerbi, A.; Vague, P.; Pieroni, G.; Raccah, D. Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy. Diabetes, 2003, 52, 2578-2585.
11. Mozaffarian, D.; Wu, J. Omega-3 fatty acids and cardiovascular disease. J. Am. Coll. Cardiol., 2011, 58, 2047-2067.
12. Corsetto, P.A.; Montorfano, G.; Zava, S.; Jovenitti, I.E.; Cremona, A.; Berra, B.; Rizzo, A.M. Effects of n-3 PUFA on breast cancer cells through their incorporation in plasma membranes. Lipids Health Dis., 2011, 12,10-73.
13. Guo, Z.; Vikbjerg, A.F.; Xu, X.B. Enzymatic modification of phospholipids for functional applications and human nutrition. Biotechnol. Adv., 2005, 23, 203-259.
14. Doig, S.D.; Diks, R.M.M. Toolbox for exchanging constituent fatty acids in lecithin. Eur. J. Lipid Sci. Technol., 2003, 105, 359-367.
15. Timmermann, F. Functional food and lipids. Oils Fats. Int., 2002, 18, 18-19.
16. Babayan, V.K. Medium chain triglycerides and structured lipids, Lipids, 1987, 22, 417-420.
17. Trivedi, R.; Singh, R. P. Modification of oils and fats to produce structured lipids. Journal of oleo Science, 2005, 54, 423-430.
18. Marangoni, A.G.; Rousseau, D. Chemical interesterification. Food Lipids, 1998, 251-281.
19. Haraldsson, G.G. The application of lipases for preparing various lipids enriched with omega-3 fatty acids. Rit. Fiskideildar., 1999, 16, 97-105.
20. Haraldsson, G.; Almarsson, O. Studies on the positional specificity of lipase from Mucor miehei during interesterification reactions of cod liver oil with n-3 polyunsaturated fatty acid and ethyl ester concentrates. Acta Chem. Scand., 1991, 45,723-730.
21. Huang, K.H.; Akoh, C. Optimization and scale-up of enzymatic synthesis of structured lipids using RSM. J. Food Sci., 1996, 61, 137-141.
22. Akoh, C.C.; Moussata, C.O. Characterization and oxidative stability of enzymatically produced fish and canola-oil-based structured lipids. J. Am. Oil Chem. Soc., 2001, 78, 25-30.
23. Jennings, B.; Akoh, C.C. Enzymatic modification of triacylglycerols of high eicosapentaenoic and docosahexaenoic acids content to produce structured lipids. J. Am. Oil. Chem. Soc., 1999, 76, 1133-1137.
24. Kawashima, A.; Shimada, Y.; Yamamoto, M.; Sugihara, A.; Nagao, T.; Komemushi, S.; Tominaga, Y. Enzymatic synthesis of high-purity structured lipids with caprylic acid at 1,3-positions and polyunsaturated fatty acid at 2-position. J. Am. Oil Chem. Soc., 2001, 78, 611-616.
25. Iwasaki, Y.; Han, J.J.; Narita, M.; Rosu, R.; Yamane, T. Enzymatic synthesis of structured lipids rom single cell oil of high docosahexaenoic acid content. J. Am. Oil Chem. Soc., 1999, 76, 563-669.
26. Shimada, Y.; Sugihara, A.; Maruyama, T.; Nagao, T.; Nakayama, H.; Nakano, H.; Tominaga, Y. Production of structured lipid containing docosahexaenoic and caprylic acids using immobilized Rhizopus delemar lipase. J. Ferment. Bioeng., 1996, 81, 299-303.
27. Hamam, F.; Shahidi, F. Synthesis of structured lipids via acidolysis of docosahexaenoic acid single cell oil (DHASCO) with capric acid. J. Agric. Food Chem., 2006 54, 2900-2906.
28. Xu, X.; Skands, A.; Jonsson, G. Production of structured lipids by lipasecatalysed interesterification in an ultrafiltration membrane reactor. Biotechnology. Letters, 2000, 22, 1667-1671.
29. Garcia, H.; Arcos, J.; Ward, D.; Hill, C. Synthesis of glycerides containing n-3 fatty acids and conjugated linoleic acid by solvent-free acidolysis of fish oil. Biotechnol. Bioeng., 2000, 587-591.
30. Irimescu, R.; Furihata, K.; Hata, K.; Iwasaki, Y.; and Yamane, T. Utilization of reaction medium-dependent regiospecificity of Candida antarctica lipase (Novozym 435) for the synthesis of 1,3-dicapryloyl-2-docosahexaenoyl. (or eicosapentaenoyl) glycerol. J. Am. Oil Chem. Soc., 2001, 78, 285-290.
31. Irimescu, R.; Furihata, K.; Hata, K.; Iwasaki, Y.; and Yamane, T. Two-step enzymatic synthesis of docosahexaenoic acid-rich symmetrically structured triacylglycerols via 2-monoacylglycerols. J. Am Oil Chem. Soc., 2001, 78, 743-748.
32. Munio, M.; Robles, A.; Esteban, L.; Gonzalez, P.; Molina, E. Synthesis of structured lipids by two enzymatic steps: Ethanolysis of fish oils and esterification of 2-monoacylglycerols. Process Biochemistry, 2009, 44, 723-730.
33. Rodríguez, A.; Esteban, L.; Martín, L.; Jiménez, M.J.; Hita, E.; Castillo, B.; González, P.A.; Robles, A. Synthesis of 2-monoacylglycerols and structured triacylglycerols rich in polyunsaturated fatty acids by enzyme catalyzed reactions. Enzyme Microb. Technol., 2012, 51, 148-155.
34. Zhang, H.; Önal, G.; Wijesundera, C.; Xu X. Practical synthesis of 1,3-oleoyl 2-docosahexaenoyl-glycerol by lipase-catalyzed reactions: An evaluation of different reaction routes Process. Biochemistry, 2009, 44, 534-539.
35. Endo, Y.; Hoshizaki, S.; Fujimoto, K. Oxidation of synthetic triacylglycerols containing eicosa-pentaenoic and docosahexaenoic acids: Effect of oxidation system and triacylglycerol structure. J. Am. Oil. Chem. Soc., 1997, 74, 1041-1045.
36. Haldorsson, A.; Magnusson, C.; Haraldsson, G.G. Chemoenzymatic synthesis of structured triacylglycerols. Tetrahedron. Lett., 2001, 42, 7675-7677.
37. Haldorsson, A.; Magnusson, C.; Haraldsson, G.G. Chemoenzymatic synthesis of structured triacylglycerols. Tetrahedron, 2003, 59, 9101-9109.
38. Magnusson, C.; Haraldsson, G.G. Chemoenzymatic synthesis of structured triacylglycerols possessing short-chain fatty acids. Tetrahedron, 2010, 66, 2728-2731.
39. Fraser, B.; Perlmutter, P.; Wijesundera, C. Practical syntheses of triacylglycerol regioisomers containing long-chain polyunsaturated fatty acids. J. Amer. Oil. Chem. Soc., 2007, 84,11-21.
40. Magnusson, C.D.; Haraldsson, G.G. Activation of n-3 polyunsaturated fatty acids as oxime esters: a novel approach for their exclusive incorporation into the primary alcoholic positions of the glycerol moiety by lipase. Chem. Phys. Lipids, 2012, 165, 712-720.
41. Chen, B.; Zhang, H.; Cheong, L.Z.; Tan, T.; Xu, X. Enzymatic production of ABA-type structured lipids containing omega 3 and medium-chain fatty acids: Effects of different acyl donors on the acyl migration rate. Food. Bioprocess. Technol., 2012, 5, 541-547.
42. Karupaiah, T.; Sundram, K. Effects of stereospecific positioning of fatty acids in triacylglycerol structures in native and randomized fats: a review of their nutritional implications. Nutr. Metab., 2007, 4, 16.
43. Nagata, J.; Kasai, M.; Negishi, Saito, M. Effects of structured lipids containing eicosapentaenoic or docosahexaenoic acid and caprylic acid on serum and liver lipid profiles in rats. BioFactors, 2004, 22,157-160.
44. Yoshida, H.; Kumamaru, J.; Mawatari, M.; Ikeda, I.; Imaizumi, K.; Tsuji, H.; Seto, A. Lymphatic absorption of seal and fish oils and their effect on lipid metabolism and eicosanoid production in rats. Biosci. Biotech. Biochem., 1996, 60, 1293-1298.
45. Beermann, C.; Jelinek, J.; Reinecker, T.; Hauenschild, A.; Boehm, G.; Klör, H-U. Short term effects of dietary medium-chain fatty acids and n-3 longchain polyunsaturated fatty acids on the fat metabolism of healthy volunteers. Lipids Health Dis., 2003, 2, 1-10.
46. St-Onge, M.P.; Lamarche, B.; Mauger, F; Jones, P.J. Consumption of a functional oil rich in phytosterols and medium-chain triglyceride oil improves plasma lipid profile in men. J. Nutr., 2003, 133,1815-1820.
47. Shirouchi, B.; Nagao, K.; Furuya, K.; Nagai, T.; Ichioka, K.; Tokairin, S.; Iida, Y.; Yanagita, T. Physiological functions of iso-type short-chain fatty acid and omega 3 polyunsaturated fatty acids containing oil in obese OLETF rats. J. Oleo. Sci., 2010, 6, 299-305.
48. Song, J.H.; Inoue, Y.; Miyazawa, T. Oxidative stability of docosahexaenoic acid-containing oils in the form of phospholipids, triacylglycerols and ethyl esters. Biosci. Biotech. Biochem., 1997, 61, 2085-2088.
49. Lyberg, A.M.; Fasoli, E.; Adlercreutz, P. Monitoring the oxidation of docosahexaenoic acid in lipids. Lipids, 2005, 969-979.
50. Rossmeisl, M.; Jilkova, Z.; Kuda, O.; Jelenik, T.; Medrikova, D.; Stankova, B.; Kristinsson, B.; Haraldsson, G.G.; Svensen, H.; Stoknes, I.; Sjövall, P.; Magnusson, Y.; Balvers, M.; Verhoeckx, K.; Tvrzicka, E.; Bryhn, M.; Kopecky, J. Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids. PLoS. One, 2012, 7, 1-13.
51. Vigerust, N.; Bjorndal, B.; Bohov, P.; Brattelid, T.; Svardal, A.; Berge, R. Krill oil versus fish oil in modulation of inflammation and lipid metabolism in mice transgenic for TNF-α. Eur. J. Nutr., 2012, Aug 25.
52. 13C]DHA in phosphatidylcholine. J. Lipid. Res., 1999, 40, 1867-1874
53. Wijendran, V.; Huang, M.C.; Diau, G.Y.; Boehm, G.; Nathanielsz, P.W.; Brenna, J.T. Efficacy of dietary arachidonic acid provided as triglyceride or phospholipid as substrates for brain arachidonic acid accretion in baboon neonates. Pediatr. Res., 2002, 51, 265-272.
54. Thies, F.; Pillon, P.; Moliere, P.; Lagarde, M.; Lecerf, J. Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain. Am. J. Physiol., 1994, R1273-R1279.
55. Bernoud, N.; Fenart, L.; Moliere, P.; Dehouck, M.P.; Lagarde, M.; Cecchelli, M.; Lecerf, J. Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid. J. Neurochem., 1999, 72, 338-345.
56. Jim, M.; Hung, N.; Yoo, J.; Kim, M.; Sok, D-E. Suppressive effect of docosahexaenoyl-lysophosphatidylcholine and 17-hydroxydocosahexaenoyllysophosphatidylcholine on levels of cytokines in spleen of mice treated with lipopolysaccharide. Eur. J. Lipid Sci. Technol., 2012, 114, 114-122.
57. Haraldsson, G.G.; Thorarensen, A. Preparation of phospholipids highly enriched with n-3 polyunsaturated fatty acids by lipase. J. Am. Oil Chem. Soc., 1999, 76, 1143-1149.
58. Poisson, L.; Devos, M.; Godet, S.; Ergan, F.; Pencreac'h, G. Acyl migration during deacylation of phospholipids rich in docosahexaenoic acid (DHA): an enzymatic approach for evidence and study. Biotechnol. Lett., 2009, 31, 743-749.
59. Croset, M.; Brossard, N.; Polette, A.; Lagarde, M. Caracterization of plasma unsaturated lysophosphatidylcholine in human and rat. Biochem. J., 2000, 345, 61-67.
60. Adlercreutz, P.; Lyberg, A.M.; Adlercreutz, D. Enzymatic fatty acid exchange in glycero-phospholipids. Eur. J. Lipid Sci. Technol., 2003, 105, 638-645.
61. 2-mediated esterification with food-compatible reagents. J. Oleo. Sci.; 2010, 59, 375-380.
62. Lyberg, A.M.; Adlercreutz, D.;Adlercreutz, P. Enzymatic and chemical synthesis of phosphatidylcholine regioisomers containing eicosapentaenoic acid or docosahexaenoic acid. Eur J Lipid Sci. Technol., 2005, 107, 279-280.
63. 1-catalyzed synthesis of phospholipids enriched in n-3 polyunsaturated fatty acid residues Enz. Microb. Technol., 2007,40,1130-1135.
64. Baeza-Jiménez, J.; Noriega-Rodríguez, H.; García, H.; Otero, C. Structured phosphatidylcholine with elevated content of conjugated linoleic acid: Optimization by response surface methodology. Eur. J. Lipid Sci. Technol., 2012,114, 1261-1267.
65. 2-catalyzed acidolysis. J. Biotechnol., 2007, 128, 545-554.
66. Polette, A.; Deshayes, C.; Chantegrel, B.; Croset, M.; Armstrong, JM.; Lagarde, M. Synthesis of acetyl, docosahexaenoyl-glycerophosphocholine and its characterization using nuclear magnetic resonance. Lipids, 1999, 34, 1333-37.
67. Lagarde, M.; Guichardant, M.; Picq, M.; Michaud, S.; Doutheau, A. Method for preparing acetyl, docosahexaenoyl-glycerophosphocholine and use thereof for the delivery of polyunsaturated fatty acids. WIPO Patent Application WO/068413/2008.
68. Maligan, J.M.; Estiasih, T.; Kusnadi, J. Structured phospholipids from commercial soybean lecithin containing omega-3 fatty acids reduces atherosclerosis risk in male Sprague dawley rats which fed with an atherogenic diet. World academy of science, Engineering and technology, 2012, 69, 552-558.
69. Chauveau, F.; Cho, T.H.; Perez, M.; Guichardant, M.; Riou, A.; Aguettaz, P.; Picq, M.; Lagarde, M.; Berthezene, Y.; Nighoghossian, N.; Wiart, M. Braintargeting form of docosahexaenoic acid for experimental stroke treatment: MRI evaluation and anti-oxidant impact. Curr. Neurovasc. Res., 2011, 8, 95-102.
70. Zerouga, M.; Stillwell, M.; Jenski, L. Synthesis of a novel phosphatidylcholine conjugated to docosahexaenoic acid and methotrexate that inhibits cell proliferation. Anti-Cancer Drugs, 2002, 3, 301-311.
71. Huang, L.; Hung, N.; Sok, D-E.; Kim, M. Lysophosphatidylcholine containing docosahexaenoic acid at the sn-1 position is anti-inflammatory. Lipids, 2010, 45, 225-236.
72. Serhan, C.N.; Petasis, NA. Resolvins and protectins in inflammation resolution. Chem. Rev., 2011 111, 5922-5943.
73. Kohli, P.; Levy, B.D. Resolvins and protectins mediating solutions to inflammation. Brit. J. Pharm., 2009, 158, 960-971.